#744 on the corporate holders of 809 holders
SR One Capital Partners I, LP
10% owner at Design Therapeutics.
$60.8M
in disclosed stock, −$979K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 744th of 809
- Companies held
- 1
- Largest holding
- DSGN, 100.0% of total
- Latest SEC filing
- Dec 20, 2022
What the $60.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Design Therapeutics DSGN Common Stock | Directly | 6,526,476 | $9.32 | $60.8M | 100.0% | Form 4, Dec 20, 2022 |
Share counts are the amounts SR One Capital Partners I, LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 741 | Dimension Capital II, L.P. Director, Odyssey Therapeutics | $61.1M |
| 742 | E.J. Elliott, LLC 10% owner, Gencor Industries | $61.1M |
| 743 | American Tower Corp /ma/ Insider, AST SpaceMobile | $60.9M |
| 744 | SR One Capital Partners I, LP 10% owner, Design Therapeutics | $60.8M |
| 745 | Drive Capital Overdrive Fund I (te), L.P. 10% owner, Root | $60.6M |
| 746 | Drive Capital Overdrive Ignition Fund I, L.P. 10% owner, Root | $60.6M |
| 747 | Dragsa 96 LLC 10% owner, Amylyx Pharmaceuticals | $60.3M |
Other Design Therapeutics insiders
All DSGN insiders- John P. Schmid$623KDirector. #11065 overall
Questions
How much stock does SR One Capital Partners I, LP own?
SR One Capital Partners I, LP holds $60,826,756 in listed stock based on SEC filings and current prices, mostly Design Therapeutics (DSGN). That ranks 744th on the Stock Rich List.
Is this SR One Capital Partners I, LP's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.